ATE183739T1 - N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie - Google Patents

N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie

Info

Publication number
ATE183739T1
ATE183739T1 AT92121896T AT92121896T ATE183739T1 AT E183739 T1 ATE183739 T1 AT E183739T1 AT 92121896 T AT92121896 T AT 92121896T AT 92121896 T AT92121896 T AT 92121896T AT E183739 T1 ATE183739 T1 AT E183739T1
Authority
AT
Austria
Prior art keywords
amnesia
prevention
treatment
acylpyrrolidine
preparation
Prior art date
Application number
AT92121896T
Other languages
English (en)
Inventor
Masaaki Toda
Shuichi Shinbayashida Ohuchida
Nishigyo-Ku Cho
Hiroyuki Ohno
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE183739T1 publication Critical patent/ATE183739T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
AT92121896T 1988-04-08 1989-04-06 N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie ATE183739T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8528888 1988-04-08

Publications (1)

Publication Number Publication Date
ATE183739T1 true ATE183739T1 (de) 1999-09-15

Family

ID=13854381

Family Applications (2)

Application Number Title Priority Date Filing Date
AT92121896T ATE183739T1 (de) 1988-04-08 1989-04-06 N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie
AT89106061T ATE117292T1 (de) 1988-04-08 1989-04-06 Antiamnesische pyrrolidin-derivate.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT89106061T ATE117292T1 (de) 1988-04-08 1989-04-06 Antiamnesische pyrrolidin-derivate.

Country Status (7)

Country Link
US (1) US5053414A (de)
EP (3) EP0965585A1 (de)
KR (1) KR0128160B1 (de)
AT (2) ATE183739T1 (de)
DE (2) DE68929059T2 (de)
ES (1) ES2070135T3 (de)
GR (1) GR3015831T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340284C (en) * 1987-03-19 1998-12-22 Zeneca Inc. Herbicidal substituted cyclic diones
JP2691442B2 (ja) * 1989-02-20 1997-12-17 株式会社ヤクルト本社 新規なプロリン誘導体
IT1241415B (it) * 1990-03-05 1994-01-14 Yason Srl Derivato dell'acido s-(2-tenoil)-tiolattico ad attivita' farmacologica
FI925500A7 (fi) * 1990-06-04 1992-12-03 Pfizer Aromaattisia pyrrolidiini- ja tiatsolidiiniamideja
AU643300B2 (en) * 1990-06-07 1993-11-11 Zeria Pharmaceutical Co., Ltd. Novel arylalkanoylamine derivative and drug containing the same
EP0468469A2 (de) * 1990-07-27 1992-01-29 Japan Tobacco Inc. Prolinderivate
US5506256A (en) * 1990-07-27 1996-04-09 Yoshitomi Pharmaceutical Industries, Ltd. Proline derivatives possessing prolyl endopeptidase-inhibitory activity
FR2669029B1 (fr) * 1990-11-14 1994-09-02 Adir Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2681864B1 (fr) * 1991-09-27 1995-03-31 Adir Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2004098591A2 (en) 2003-05-05 2004-11-18 Probiodrug Ag Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
AU2004290499C1 (en) 2003-11-03 2011-02-24 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
CA2554809C (en) 2004-02-05 2014-04-29 Probiodrug Ag Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase
US8034940B2 (en) 2006-08-09 2011-10-11 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (de) 2007-04-18 2014-12-24 Probiodrug AG Thioharnstoffderivate als glutaminylcyclaseinhibitoren
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
NZ602312A (en) 2010-03-10 2014-02-28 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (de) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazolderivate als glutaminylcyclase-hemmer
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE5255T1 (de) * 1978-09-05 1983-11-15 American Cyanamid Company Substituierte omega-aroyl(propionyl oder butyryl)-l-proline, diese enthaltende pharmazeutische verbindungen und verfahren zu ihrer herstellung.
US4880827A (en) * 1986-03-18 1989-11-14 Sumitomo Pharmaceuticals Company, Ltd. Pyrrolidine derivatives having inhibitory action for proline specific endopepidase
DE3786229T2 (de) * 1986-11-20 1993-10-07 Ono Pharmaceutical Co Prolinalderivate.
DE3875361T2 (de) * 1987-02-23 1993-03-25 Ono Pharmaceutical Co Thiazolidin-derivate.
US4851428A (en) * 1987-03-06 1989-07-25 American Cyanamid Company Mono- and diepoxide derivatives of Δ22-LL-F28249 compounds
DE3712364A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue pyrrolidin-2-(1,3-dicarbonyl)-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
DE3742431A1 (de) * 1987-12-15 1989-07-13 Hoechst Ag Neue derivate cyclischer aminosaeuren, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH0662591B2 (ja) * 1988-12-14 1994-08-17 株式会社ヤクルト本社 新規なチオプロリン誘導体
JP2691442B2 (ja) * 1989-02-20 1997-12-17 株式会社ヤクルト本社 新規なプロリン誘導体

Also Published As

Publication number Publication date
EP0537802A2 (de) 1993-04-21
KR0128160B1 (ko) 1998-04-04
DE68920632D1 (de) 1995-03-02
EP0537802B1 (de) 1999-08-25
EP0345428B1 (de) 1995-01-18
EP0345428A1 (de) 1989-12-13
EP0537802A3 (en) 1993-06-02
ATE117292T1 (de) 1995-02-15
EP0965585A1 (de) 1999-12-22
DE68920632T2 (de) 1995-06-14
ES2070135T3 (es) 1995-06-01
US5053414A (en) 1991-10-01
KR900016122A (ko) 1990-11-12
DE68929059T2 (de) 2000-01-27
GR3015831T3 (en) 1995-07-31
DE68929059D1 (de) 1999-09-30

Similar Documents

Publication Publication Date Title
ATE183739T1 (de) N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie
ATE169914T1 (de) Piperazin-derivate und ihre verwendung als calmodulin-inhibitoren
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
DK1105393T3 (da) Bicykliske piperidin- og piperazinforbindelser med 5-HT6-receptoraffinitet
ATE87306T1 (de) Prolinalderivate.
FI982436A0 (fi) Kondensoituneet heterosykliset yhdisteet
ES2103287T3 (es) Nuevos derivados de tiazolidina.
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
ATE137805T1 (de) Verfahren zur erhöhung von chemilumineszenz
DE3783754D1 (de) Prolin-derivate.
AT379800B (de) Verfahren zur herstellung von neuen 2-oxazetidin-derivaten
DE3675778D1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
ATE226192T1 (de) Penizillaminamid-derivate
ATE47592T1 (de) Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen.
BR8903043A (pt) Processo para preparacao de compostos
ATE225660T1 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz
DE3864463D1 (de) Gamma-l-glutanyl-4-nitoanilid-derivate und verfahren zur bestimmung von gamma-gtp-aktivitaet unter verwendung dieser derivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee